Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BMO Capital Maintains Outperform on Kinaxis, Raises Price Target to $230

BMO Capital maintains Kinaxis (TSX:KXS) with a Outperform and raises the price target from $195 to $230.

byBenzinga Newsdesk

November 8, 2021

1 minute read

BMO Capital maintains Kinaxis (TSX:KXS) with a Outperform and raises the price target from $195 to $230.

Analyst Ratings

Analyst Expectations for Karuna Therapeutics’s Future

By Benzinga Insights

Today, 4:34 AM

Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

KRTX

Stephens & Co. Downgrades Balchem to Equal-Weight, Raises Price Target to $145

By Benzinga Newsdesk

Today, 4:34 AM

Stephens & Co. analyst Mark Connelly downgrades Balchem (NASDAQ:BCPC) from Overweight to Equal-Weight and raises the price target from $140 to $145.

BCPC

Nio Rallies As EV Maker Confirms Dec. 18 ‘Nio Day’ Event Themed ‘Hello World’

By Shanthi Rexaline

Today, 4:34 AM

Nio Inc - ADR (NYSE: NIO) shares, which on Friday tumbled to their lowest level since mid-May, have been on the mend. After a modest gain Monday, the stock's rally has picked up the pace.

NIO

Traders Added $150B To The Market Cap Of AMC, GME And 48 Other ‘Meme Stocks’ In 2021: Report

By Samyuktha Sriram

Today, 4:34 AM

Without a doubt, market participants can agree on the fact that 2021 was the year of the meme stock.

$DOGE

BMO Capital Maintains Outperform on Kinaxis, Raises Price Target to $230

Related Posts

Analyst Expectations for Karuna Therapeutics’s Future

Stephens & Co. Downgrades Balchem to Equal-Weight, Raises Price Target to $145

Nio Rallies As EV Maker Confirms Dec. 18 ‘Nio Day’ Event Themed ‘Hello World’

Traders Added $150B To The Market Cap Of AMC, GME And 48 Other ‘Meme Stocks’ In 2021: Report